Schoenberg Mark
SEC CIK 1763581 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Chief Medical Off | 59.9K | $2,096 | $5.28M | 50 | 2021-07-26 | 2026-09-08 |
Most active insiders at URGN, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Schoenberg Mark | Chief Medical Off | — | $4.48M |
| 2 | Smith Jason Drew | GC | — | $211.9K |
| 3 | Degnan Chris | CFO | — | $37.1K |
| 4 | Wildman Daniel George | Dir | — | — |
| 5 | WEN LEANA | Dir | — | — |
| 6 | Holden Stuart | Dir | — | — |
| 7 | Robinson James A. Jr. | Dir | — | — |
| 8 | BUTITTA CYNTHIA M | Dir | — | — |
Transactions 50
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-09-09 14:37 | 2026-09-07 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +1,667 | 60.8K | +3% | — |
| D | 2026-09-09 14:37 | 2026-09-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $42.92 | -871 | 59.9K | -1% | -$37.4K |
| 2026-08-24 17:03 | 2026-08-20 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $47.05 | -60.7K | 59.1K | -51% | -$2.85M | |
| T | 2026-07-10 14:17 | 2026-07-09 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $40.00 | -10.0K | 119.8K | -8% | -$400.0K |
| T | 2026-06-24 10:22 | 2026-06-22 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $35.01 | -10.0K | 129.8K | -7% | -$350.1K |
| D | 2026-06-09 13:59 | 2026-06-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +10.0K | 145.0K | +7% | — |
| D | 2026-06-09 13:59 | 2026-06-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $27.30 | -5,222 | 139.8K | -4% | -$142.6K |
| T | 2026-05-11 15:54 | 2026-05-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $30.00 | -10.0K | 135.0K | -7% | -$300.0K |
| M | 2026-02-04 | 2026-02-03 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $19.69 | -7,373 | 150.5K | -5% | -$145.2K |
| DM | 2026-02-03 | 2026-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +13.3K | 152.4K | +10% | — |
| 2025-11-20 | 2025-11-19 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $25.00 | -10.0K | 139.0K | -7% | -$250.0K | |
| D | 2025-09-09 | 2025-09-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $19.11 | -871 | 149.0K | -0.6% | -$16.6K |
| D | 2025-09-09 | 2025-09-07 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +1,667 | 149.9K | +1% | — |
| 2025-08-13 | 2025-08-11 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $17.69 | -10.0K | 148.2K | -6% | -$176.9K | |
| 2025-07-30 | 2025-07-28 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $19.14 | -5,149 | 158.2K | -3% | -$98.6K | |
| 2025-07-30 | 2025-07-28 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +10.0K | 163.4K | +7% | — | |
| D | 2025-06-11 | 2025-06-08 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +10.0K | 158.5K | +7% | — |
| D | 2025-06-11 | 2025-06-09 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $7.37 | -5,162 | 153.4K | -3% | -$38.0K |
| DM | 2025-02-04 | 2025-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +8,000 | 146.4K | +6% | — |
| DM | 2025-02-04 | 2025-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $11.14 | -4,551 | 148.5K | -3% | -$50.7K |
| D | 2024-09-12 | 2024-09-09 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +1,666 | 145.9K | +1% | — |
| D | 2024-09-12 | 2024-09-09 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $13.08 | -859 | 145.1K | -0.6% | -$11.2K |
| D | 2024-06-11 | 2024-06-10 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $13.08 | -5,153 | 144.3K | -3% | -$67.4K |
| D | 2024-06-11 | 2024-06-10 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +10.0K | 149.4K | +7% | — |
| 2024-03-20 | 2024-03-18 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $14.05 | -12.0K | 139.4K | -8% | -$168.6K | |
| MA | 2024-02-05 | 2024-02-01 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale | $15.78 | -3,789 | 150.0K | -2% | -$59.8K |
| DM | 2024-02-02 | 2024-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +6,666 | 153.3K | +5% | — |
| DM | 2024-02-02 | 2024-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $15.74 | -3,789 | 149.4K | -2% | -$59.6K |
| DM | 2023-02-02 | 2023-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $10.12 | -1,900 | 146.9K | -1% | -$19.2K |
| DM | 2023-02-02 | 2023-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +3,833 | 147.1K | +3% | — |
| D | 2023-01-23 | 2023-01-20 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | $5.00 | +122.7K | 146.6K | +512% | +$613.4K |
| D | 2022-11-02 | 2022-10-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 24.2K | +2% | — |
| D | 2022-11-02 | 2022-10-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $11.85 | -258 | 23.9K | -1% | -$3,057 |
| D | 2022-08-25 | 2022-08-01 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $7.81 | -259 | 23.7K | -1% | -$2,023 |
| D | 2022-08-25 | 2022-07-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 24.0K | +2% | — |
| D | 2022-05-03 | 2022-04-30 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $6.62 | -254 | 23.5K | -1% | -$1,681 |
| D | 2022-05-03 | 2022-04-30 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 23.7K | +2% | — |
| DM | 2022-02-02 | 2022-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +2,500 | 24.3K | +11% | — |
| DM | 2022-02-02 | 2022-01-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $7.58 | -1,374 | 22.3K | -6% | -$10.4K |
| D | 2022-01-28 | 2022-01-26 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +209 | 22.2K | +1.0% | — |
| D | 2022-01-28 | 2022-01-26 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $8.09 | -111 | 22.1K | -0.5% | -$897.99 |
| 2021-11-19 | 2021-11-18 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | P - Purchase | $13.10 | +160 | 22.0K | +0.7% | +$2,096 | |
| D | 2021-11-02 | 2021-10-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 22.1K | +2% | — |
| D | 2021-11-02 | 2021-11-01 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $17.16 | -258 | 21.8K | -1% | -$4,427 |
| D | 2021-10-28 | 2021-10-27 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $16.32 | -107 | 21.6K | -0.5% | -$1,746 |
| D | 2021-10-28 | 2021-10-26 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +208 | 21.7K | +1.0% | — |
| D | 2021-08-03 | 2021-07-31 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | +500 | 21.7K | +2% | — |
| D | 2021-08-03 | 2021-08-02 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $15.64 | -243 | 21.5K | -1% | -$3,801 |
| D | 2021-07-28 | 2021-07-26 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | M - OptEx | — | -208 | 20.9K | -1.0% | — |
| D | 2021-07-28 | 2021-07-26 | URGN | UroGen Pharma Ltd. | Schoenberg Mark | Chief Medical Off | S - Sale+OE | $15.30 | -103 | 20.8K | -0.5% | -$1,576 |
Purchase Sale Sale after option exercise All abbreviations